These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9848638)

  • 41. Balance of Benefit and Risk in Intravenous Iron Treatment in Chronic Kidney Disease.
    Fishbane S
    Semin Nephrol; 2016 Mar; 36(2):119-23. PubMed ID: 27236133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety of Intravenous Iron - Cosmofer and Monofer Therapy in Peritoneal Dialysis and Non-Dialysis-Dependent Chronic Kidney Disease Patients.
    Sivakumar C; Jubb VM; Lamplugh A; Bhandari S
    Perit Dial Int; 2019; 39(2):192-195. PubMed ID: 30858290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients.
    Folkert VW
    Nephrol Nurs J; 2003 Oct; 30(5):571-6, 584. PubMed ID: 14621635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anemia in Peritoneal Dialysis Patients; Iron Repletion, Current and Future Therapies.
    Zeidan A; Bhandari S
    Perit Dial Int; 2017 1-2; 37(1):6-13. PubMed ID: 28153964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous iron supplementation in end-stage renal disease patients.
    Matzke GR
    Am J Kidney Dis; 1999 Mar; 33(3):595-7. PubMed ID: 10070926
    [No Abstract]   [Full Text] [Related]  

  • 46. A study of parenteral iron regimens in hemodialysis patients.
    Besarab A; Kaiser JW; Frinak S
    Am J Kidney Dis; 1999 Jul; 34(1):21-8. PubMed ID: 10401011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Use of Parenteral Iron Therapy for the Treatment of Postpartum Anemia.
    Nash CM; Allen VM
    J Obstet Gynaecol Can; 2015 May; 37(5):439-442. PubMed ID: 26168105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anemia management practices in peritoneal dialysis patients. Case study of the anemic patient.
    MacCracken MA
    Nephrol Nurs J; 2001 Aug; 28(4):435-8. PubMed ID: 12143466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
    Michael B; Coyne DW; Fishbane S; Folkert V; Lynn R; Nissenson AR; Agarwal R; Eschbach JW; Fadem SZ; Trout JR; Strobos J; Warnock DG;
    Kidney Int; 2002 May; 61(5):1830-9. PubMed ID: 11967034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The comparative safety of various intravenous iron preparations in chronic kidney disease patients.
    Anirban G; Kohli HS; Jha V; Gupta KL; Sakhuja V
    Ren Fail; 2008; 30(6):629-38. PubMed ID: 18661414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IV iron use in patients with higher serum ferritin: case study on anemia in kidney disease.
    Larson K
    Nephrol Nurs J; 2008; 35(2):184-93; quiz 194-5. PubMed ID: 18472686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of inflammation on nutrition, iron status, and erythropoietin responsiveness in ESRD patients.
    Bistrian BR; Carey LA
    Nephrol Nurs J; 2000 Dec; 27(6):616-22. PubMed ID: 16649343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Achieving target hematocrit in dialysis patients: new concepts in iron management.
    Nissenson AR
    Am J Kidney Dis; 1997 Dec; 30(6):907-11. PubMed ID: 9398140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical perspective: iron replacement therapy in chronic heart failure.
    Cowie MR; Lucas R
    Int J Clin Pract; 2011 Jun; 65(6):645-8. PubMed ID: 21564435
    [No Abstract]   [Full Text] [Related]  

  • 55. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.
    Plummer ES; Crary SE; McCavit TL; Buchanan GR
    Pediatr Blood Cancer; 2013 Nov; 60(11):1747-52. PubMed ID: 23832487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Parenteral iron therapy: problems and possible solutions].
    Hoigné R; Breymann C; Künzi UP; Brunner F
    Schweiz Med Wochenschr; 1998 Apr; 128(14):528-35. PubMed ID: 9592894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis.
    Shah HH; Hazzan AD; Fishbane S
    Semin Nephrol; 2016 Mar; 36(2):124-9. PubMed ID: 27236134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stability of iron concentrations in peritoneal dialysis solution bags.
    Park SE; Twardowski ZJ; Moore HL
    Perit Dial Int; 1997; 17(2):210-1. PubMed ID: 9159851
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of an intravenous iron dextran regimen on iron stores, hemoglobin, and erythropoietin requirements in hemodialysis patients.
    Park L; Uhthoff T; Tierney M; Nadler S
    Am J Kidney Dis; 1998 May; 31(5):835-40. PubMed ID: 9590194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erythropoietic agents in peritoneal dialysis.
    Muirhead N
    Perit Dial Int; 2005; 25(6):547-50. PubMed ID: 16411519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.